08:00 , Feb 10, 2014 |  BC Week In Review  |  Company News

InSite, Bess Royalty, SWK Holdings deal

InSite said it received a $1 million milestone payment from Bess Royalty and the SWK Funding LLC subsidiary of SWK due to 2013 net sales of Besivance besifloxacin ophthalmic solution reaching undisclosed levels. Last April,...
07:00 , Apr 8, 2013 |  BC Week In Review  |  Company News

InSite, Bausch + Lomb, Bess Royalty, SWK Holdings deal

InSite sold its royalty on sales of Besivance besifloxacin ophthalmic solution to Bess Royalty and the SWK Funding LLC subsidiary of SWK for up to $16 million. InSite will receive $15 million at closing and...